Biovest International develops active personalized immunotherapies, markets state-of-the-art hollow fiber bio-production instruments, and provides custom cell cultural services. Through its partnership with the National Cancer Institute, Biovest has developed a patient-specific cancer vaccine, BiovaxID®, for which three clinical trials demonstrate evidence of safety and efficacy for the treatment of indolent follicular non-Hodgkin’s lymphoma. For more information visit the company’s Web site at www.biovest.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: